发明名称 COPOLYMERS FOR SUPPRESSION OF AUTOIMMUNE DISEASES, AND METHODS OF USE
摘要 <p>Random three- and four-amino acid copolymers having lengths of 14-,35- and 50-amino acid residues are provided. Fifty-mers of FEAK were effective inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones. These copolymers efficiently suppressed EAE induced in susceptible SJL/J (H-2<S>) strain of mice with either whole spinal cord homogenate (WSCH) or with the encephalitogenic epitope PLP 139-151. YFAK 50-mer having a molar ratio of about y 0.8:F 0.2 inhibited binding of biotinylated MBP 85-99 epitope to HLA-DR-2 molecules more efficiently than either unlabeled MBP 85-99 or Copaxone3. YFAK and FAK copolymers efficiently suppressed EAE induced in SJL/J (H-2<S>) mice with the encephalitogenic epitope PLP 139-151. Copolymers YFK, VYAK and tryptophan-containing VWAK were efficacious in alleviating severity and duration of symptoms of EAE induced by MBP 85-99, in a humanized mouse model expressing genes for both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and for a T cell receptor from an MS patient.</p>
申请公布号 WO03029276(A3) 申请公布日期 2003.11.27
申请号 WO2002US31399 申请日期 2002.10.03
申请人 PRESIDENT AND FELLOWS OF HARVARD COLLEGE;STROMINGER, JACK, L.;FRIDKIS-HARELI, MASHA 发明人 STROMINGER, JACK, L.;FRIDKIS-HARELI, MASHA
分类号 A61K45/00;A61K38/00;A61K38/20;A61K38/21;A61K38/55;A61P3/10;A61P5/14;A61P7/04;A61P17/06;A61P21/04;A61P25/00;A61P29/00;A61P31/04;A61P37/02;A61P43/00;C07K14/00;(IPC1-7):A61K38/00;A61K39/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利